Skip to main content
Shanghai INT Medical Instruments Co., Ltd. logo

Shanghai INT Medical Instruments Co., Ltd. — Investor Relations & Filings

Ticker · 1501 ISIN · CNE100003NH7 HKEX Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2026-05-28 Governance Information
Country HK Hong Kong
Listing HKEX 1501

About Shanghai INT Medical Instruments Co., Ltd.

http://www.int-medical.com

Shanghai INT Medical Instruments Co., Ltd. is a leading developer and manufacturer of interventional medical devices, primarily focusing on cardiovascular, peripheral vascular, neurovascular, cardiac electrophysiology, and structural heart disease segments. The company maintains a strong market position due to its complete industrial chain, encompassing independent mold development, equipment manufacturing, and sterilization capabilities. This vertical integration is a key differentiator. INT Medical emphasizes technological innovation, holding extensive intellectual property, including hundreds of authorized patents and numerous product registrations (CE and FDA). Its products are exported globally to over 90 countries and regions.

Recent filings

Filing Released Lang Actions
Articles of Association
Governance Information Classification · 99% confidence The document is the company’s Articles of Association (bylaws) outlining governance structure: general provisions, share capital, shareholder meetings, board of directors, senior management, etc. This is a core corporate governance charter rather than an operational report or announcement. It fits the Governance Information category.
2026-05-28 English
(1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 MAY 2026; AND (2) PAYMENT OF FINAL DIVIDEND
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is an announcement published on the HKSE platform detailing the poll results of the company’s 2025 Annual General Meeting held on 28 May 2026 (listing each resolution and votes for/against/abstain) and subsequent information on the final dividend payment. It does not contain the full annual report or financial statements themselves, but rather the official voting outcomes at the AGM, matching the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-28 English
TERMINATION OF DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF NEW SHARES IN BRONCUS
Capital/Financing Update Classification · 93% confidence The document is an official announcement under the Hong Kong Listing Rules regarding the termination of a subscription agreement for new shares (a planned financing transaction). It provides details of the capital/financing activity (a subscription of new shares) and its termination, without presenting full financial statements or other report content. This aligns with the Capital/Financing Update category.
2026-05-26 English
INSIDE INFORMATION GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATION
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement by Shanghai INT Medical Instruments Co., Ltd. regarding the Stock Exchange’s approval for the conversion of Domestic Shares into H Shares and the related change in the company’s share capital structure. It contains detailed share numbers, percentages and references to listing procedures under the Listing Rules. This constitutes a capital structure change/ new share listing announcement, matching the “Share Issue/Capital Change” category (Code: SHA).
2026-05-13 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 23.18% EQUITY INTEREST IN THE TARGET COMPANY
M&A Activity Classification · 91% confidence The document is a Hong Kong Exchange announcement disclosing a “discloseable transaction” under Chapter 14 of the Listing Rules for the acquisition of a 23.18% equity interest in a target company, detailing share transfer agreements, consideration, conditions precedent, and Listing Rules implications. This is an M&A transaction announcement, not a financial report, earnings release, or other category. Therefore, it falls squarely under M&A Activity (TAR).
2026-05-12 English
INSIDE INFORMATION ISSUANCE OF FILING NOTICE BY CSRC FOR THE H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY
Share Issue/Capital Change Classification · 85% confidence The document is an “Inside Information” announcement under Hong Kong Listing Rules disclosing the CSRC’s filing notice for the full circulation application (conversion of Domestic Shares into H Shares). There is no financial statement data, no dividend, no board changes, no earnings, and no legal proceedings. This is a capital structure change announcement (conversion/listing of shares). Hence it falls under Share Issue/Capital Change (SHA).
2026-05-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.